Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Livermore

Showing results (51-60 of 245) with videos related to

Pageof 25
Sort By:
The Journal of Antimicrobial Chemotherapy|April 1, 1994
Comparative in-vitro activity of biapenem and other carbapenems against Haemophilus influenzae isolates with known resistance mechanisms to ampicillinS F Yeo, D M Livermore
The Journal of Antimicrobial Chemotherapy|March 1, 1994
Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistanceH Y Chen, D M Livermore
The Journal of Antimicrobial Chemotherapy|June 18, 1998
Worldwide emergence of carbapenem-resistant Acinetobacter sppM Afzal-Shah, D M Livermore
Journal of Medical Microbiology|November 1, 1986
Dissociation of surface properties and "intrinsic" resistance to beta lactams in Pseudomonas aeruginosaD M Livermore, T L Pitt
The Journal of Antimicrobial Chemotherapy|October 24, 1997
Potentiation of beta-lactams against Pseudomonas aeruginosa strains by Ro 48-1256, a bridged monobactam inhibitor of AmpC beta-lactamasesD M Livermore, H Y Chen
The Journal of Infectious Diseases|April 1, 1987
Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosaD M Livermore, Y J Yang
The Journal of Antimicrobial Chemotherapy|February 8, 2000
Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998G S Babini, D M Livermore
The Journal of Antimicrobial Chemotherapy|January 11, 2000
Effect of conalbumin on the activity of Syn 2190, a 1,5 dihydroxy-4-pyridon monobactam inhibitor of AmpC beta-lactamasesG S Babini, D M Livermore
The Journal of Antimicrobial Chemotherapy|November 1, 1993
Activity of cefepime and other beta-lactam antibiotics against permeability mutants of Escherichia coli and Klebsiella pneumoniaeH Y Chen, D M Livermore
Journal of Medical Microbiology|April 1, 1994
Effect of inoculum size on the in-vitro susceptibility to beta-lactam antibiotics of Moraxella catarrhalis isolates of different beta-lactamase typesS F Yeo, D M Livermore
Pageof 25

Showing results (51-60 of 245) with videos related to

Sort By:
Pageof 25
The Journal of Antimicrobial Chemotherapy|April 1, 1994
Comparative in-vitro activity of biapenem and other carbapenems against Haemophilus influenzae isolates with known resistance mechanisms to ampicillinS F Yeo, D M Livermore
The Journal of Antimicrobial Chemotherapy|March 1, 1994
Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistanceH Y Chen, D M Livermore
The Journal of Antimicrobial Chemotherapy|June 18, 1998
Worldwide emergence of carbapenem-resistant Acinetobacter sppM Afzal-Shah, D M Livermore
Journal of Medical Microbiology|November 1, 1986
Dissociation of surface properties and "intrinsic" resistance to beta lactams in Pseudomonas aeruginosaD M Livermore, T L Pitt
The Journal of Antimicrobial Chemotherapy|October 24, 1997
Potentiation of beta-lactams against Pseudomonas aeruginosa strains by Ro 48-1256, a bridged monobactam inhibitor of AmpC beta-lactamasesD M Livermore, H Y Chen
The Journal of Infectious Diseases|April 1, 1987
Beta-lactamase lability and inducer power of newer beta-lactam antibiotics in relation to their activity against beta-lactamase-inducibility mutants of Pseudomonas aeruginosaD M Livermore, Y J Yang
The Journal of Antimicrobial Chemotherapy|February 8, 2000
Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998G S Babini, D M Livermore
The Journal of Antimicrobial Chemotherapy|January 11, 2000
Effect of conalbumin on the activity of Syn 2190, a 1,5 dihydroxy-4-pyridon monobactam inhibitor of AmpC beta-lactamasesG S Babini, D M Livermore
The Journal of Antimicrobial Chemotherapy|November 1, 1993
Activity of cefepime and other beta-lactam antibiotics against permeability mutants of Escherichia coli and Klebsiella pneumoniaeH Y Chen, D M Livermore
Journal of Medical Microbiology|April 1, 1994
Effect of inoculum size on the in-vitro susceptibility to beta-lactam antibiotics of Moraxella catarrhalis isolates of different beta-lactamase typesS F Yeo, D M Livermore
Pageof 25